Observational study of the persistence of treatment in psoriasic arthritis PRO-SPIRIT study. (LIL-IXE-2019-01)
COMMERCIAL POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: ELI LILLY AND COMPANY
- Execution start: 20/10/2020
- End of execution: 30/12/2025
- PI: ENRIQUE RAYA ALVAREZ